Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

SeaStar Medical Holding (ICUCW) Net Cash Flow (2023 - 2025)

SeaStar Medical Holding's Net Cash Flow history spans 3 years, with the latest figure at -$1.8 million for Q4 2025.

  • For Q4 2025, Net Cash Flow fell 577.95% year-over-year to -$1.8 million; the TTM value through Dec 2025 reached $10.2 million, up 518.44%, while the annual FY2025 figure was $10.2 million, 518.44% up from the prior year.
  • Net Cash Flow reached -$1.8 million in Q4 2025 per ICUCW's latest filing, down from $7.5 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $7.5 million in Q3 2025 to a low of -$3.8 million in Q2 2024.
  • Average Net Cash Flow over 3 years is $994416.7, with a median of $390500.0 recorded in 2023.
  • Peak YoY movement for Net Cash Flow: surged 1405.0% in 2024, then crashed 577.95% in 2025.
  • A 3-year view of Net Cash Flow shows it stood at $103000.0 in 2023, then plummeted by 355.34% to -$263000.0 in 2024, then plummeted by 577.95% to -$1.8 million in 2025.
  • Per Business Quant, the three most recent readings for ICUCW's Net Cash Flow are -$1.8 million (Q4 2025), $7.5 million (Q3 2025), and $1.0 million (Q2 2025).